Autopsy report · NCT00446329

Cinacalcet for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis

“due to financial problems”

The sponsor’s own words in the registry.

Life of this trial

• Registered 8 months after it had already started.
• 15 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 4

Sponsor

Papageorgiou General Hospital

Sponsor type

University, hospital or other

Conditions

Secondary Hyperparathyroidism

Interventions

cinacalcet

Participants

15

Sites

1

Countries

Greece

Trials that died the same way

• Effect of Tadalafil in Chronic Obstructive Lung Disease Patients Suffering From Secondary Pulmonary Hypertension
  “due to lack of finance” (85% match in meaning)
• To Study and Compare the Clinical Course and Development of Organ Failure in Severe Acute Hepatitis Without Ascites, Non-cirrhotic and Cirrhotic Patients With Ascites [Acute on Chronic Liver Failure] and Acute Deterioration of Previously Decompensated Cirrhosis.
  “Due to lack of funds” (79% match in meaning)
• Low-dose AZA, Pioglitazone, ATRA Versus Standard-dose AZA in Patients >=60 Years With Refractory AML
  “Due to financial reasons.” (76% match in meaning)
• Individualized Therapy Based of Tumoral mRNA Levels of ERCC1, RRM1 and BRCA1 in Advanced Non-Small-Cell Lung Cancer
  “Due to poor accrual” (76% match in meaning)
• Assessment of a Health Informatics System on Insulin-treated Diabetic Patients
  “financial issues” (74% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.